Table 2.

Clinical study of antitumor drugs targeting cAMP–PKA pathway (from clinicaltrials.gov)

Identifier	Title	Cancer type	Locations
NCT00004902	Tocladesine in treating patients with recurrent or refractory multiple myeloma	Multiple myeloma and plasma cell tumor	Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
NCT00021268	Tocladesine in treating patients with recurrent or progressive metastatic colorectal cancer	Colorectal cancer	Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
NCT00004864	Docetaxel and GEM 231 in treating patients with recurrent or refractory solid tumors	Unspecified adult solid tumor	Albert Einstein Comprehensive Cancer Center Bronx, New York, United States
NCT00004863	Paclitaxel and GEM 231 in treating patients with recurrent or refractory solid tumors	Unspecified adult solid tumor	Albert Einstein Comprehensive Cancer Center Bronx, New York, United States